Clinical Trial Update: Evaluation of Third-line cART Regimen in Cambodia (3DICAM) [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating a third-line combination antiretroviral therapy (cART) regimen for HIV/AIDS in Cambodia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV/AIDS | Phase 2 | Status: UNKNOWN